Literature DB >> 12101082

Recombinant human interleukin (IL)-1 beta-mediated regulation of hypoxia-inducible factor-1 alpha (HIF-1 alpha) stabilization, nuclear translocation and activation requires an antioxidant/reactive oxygen species (ROS)-sensitive mechanism.

John J Haddad1.   

Abstract

Cytokine-mediated regulation of hypoxia-inducible factor-1 alpha (HIF-1 alpha) non-hypoxic stabilization, translocation and activation is not well characterized. Furthermore, evidence that reactive oxygen species (ROS) signaling mediates interleukin (IL)-1 beta-dependent regulation of HIF-1 alpha has yet to be ascertained in alveolar epithelial cells. Recombinant human IL-1 beta induced, in a time-dependent manner, the nuclear translocation of HIF-1 alpha, an effect associated with up-regulating the activity of this transcription factor under normoxic conditions. In addition, analysis of the mode of action of IL-1 beta revealed a novel induction of intracellular ROS, including hydrogen peroxide (H(2)O(2)), the superoxide anion (O(2)(-*)) and the hydroxyl radical (*OH). The antioxidants, dimethyl sulfoxide (DMSO) and 1,3-dimethyl-2-thiourea (DMTU), purported to be prototypical scavengers of H2O2 and *OH, attenuated, in a dose-dependent manner, IL-1 beta-induced HIF-1 alpha nuclear translocation and activation. The NADPH-oxidase inhibitor, 4'-hydroxy-3'-methoxy-acetophenone (HMAP), which may affect mitochondrial ROS production, attenuated IL-1 beta-mediated nuclear translocation and activation of HIF-1 alpha. Inhibition of the mitochondrion complex I nicotinamide adenine dinucleotide phosphate-dependent oxidase by diphenylene iodonium (DPI), which blocks the conversion of ubiquinone --> ubiquinol, abrogated IL-1 beta-dependent nuclear translocation and activation of HIF-1 alpha. Similarly, interrupting the respiratory chain with potassium cyanide reversed the excitatory effect of IL-1 beta on HIF-1 alpha nuclear translocation and activation. These results indicate that a non-hypoxic pathway mediates cytokine-dependent regulation of HIF-1 alpha translocation and activation in a ROS-sensitive mechanism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12101082

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  16 in total

Review 1.  Hypoxia inducible factor (HIF) in rheumatology: low O2! See what HIF can do!

Authors:  T Gaber; R Dziurla; R Tripmacher; G R Burmester; F Buttgereit
Journal:  Ann Rheum Dis       Date:  2005-03-30       Impact factor: 19.103

Review 2.  Perinatal oxygen in the developing lung.

Authors:  Elizabeth R Vogel; Rodney D Britt; Mari Charisse Trinidad; Arij Faksh; Richard J Martin; Peter M MacFarlane; Christina M Pabelick; Y S Prakash
Journal:  Can J Physiol Pharmacol       Date:  2014-12-09       Impact factor: 2.273

3.  IL-1 is required for tumor invasiveness and angiogenesis.

Authors:  Elena Voronov; Dror S Shouval; Yakov Krelin; Emanuela Cagnano; Daniel Benharroch; Yoichiro Iwakura; Charles A Dinarello; Ron N Apte
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-21       Impact factor: 11.205

Review 4.  Natural product-derived small molecule activators of hypoxia-inducible factor-1 (HIF-1).

Authors:  Dale G Nagle; Yu-Dong Zhou
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

5.  mtDNA mutations increase tumorigenicity in prostate cancer.

Authors:  John A Petros; Amanda K Baumann; Eduardo Ruiz-Pesini; Mahul B Amin; Carrie Qi Sun; John Hall; SoDug Lim; Muta M Issa; W Dana Flanders; Seyed H Hosseini; Fray F Marshall; Douglas C Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-12       Impact factor: 11.205

6.  Sustained exposure to cytokines and hypoxia enhances excitability of oxygen-sensitive type I cells in rat carotid body: correlation with the expression of HIF-1α protein and adrenomedullin.

Authors:  Xuemei Liu; Liang He; Bruce Dinger; Larry Stensaas; Salvatore Fidone
Journal:  High Alt Med Biol       Date:  2013-03       Impact factor: 1.981

7.  New findings in osteoarthritis pathogenesis: therapeutic implications.

Authors:  Lia Pulsatelli; Olga Addimanda; Veronica Brusi; Branka Pavloska; Riccardo Meliconi
Journal:  Ther Adv Chronic Dis       Date:  2013-01       Impact factor: 5.091

8.  Hypoxia-induced IL-18 increases hypoxia-inducible factor-1alpha expression through a Rac1-dependent NF-kappaB pathway.

Authors:  Jeongki Kim; Yan Shao; Sang Yong Kim; Seyl Kim; Hyun Keun Song; Jun Ho Jeon; Hyun Woo Suh; Jin Woong Chung; Suk Ran Yoon; Young Sang Kim; Inpyo Choi
Journal:  Mol Biol Cell       Date:  2007-11-14       Impact factor: 4.138

9.  Thrombopoietin (TPO) regulates HIF-1alpha levels through generation of mitochondrial reactive oxygen species.

Authors:  Kozue Yoshida; Keita Kirito; Hu Yongzhen; Keiya Ozawa; Kenneth Kaushansky; Norio Komatsu
Journal:  Int J Hematol       Date:  2008-05-14       Impact factor: 2.490

10.  Regulation of hypoxia-inducible factor-1α (HIF-1α) expression by interleukin-1β (IL-1 β), insulin-like growth factors I (IGF-I) and II (IGF-II) in human osteoarthritic chondrocytes.

Authors:  Angelica Rossi Sartori-Cintra; Cristiane Sampaio de Mara; Danielle L Argolo; Ibsen Bellini Coimbra
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.